HRT Financial’s Establishment Labs ESTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.18M Buy
108,802
+3,790
+4% +$259K 0.02% 880
2025
Q4
$7.65M Buy
+105,012
New +$6.34M 0.02% 564
2024
Q2
Sell
-14,978
Closed -$762K 2452
2024
Q1
$762K Buy
+14,978
New +$601K ﹤0.01% 1026
2023
Q3
Sell
-4,107
Closed -$281K 2586
2023
Q2
$281K Sell
4,107
-25,755
-86% -$1.78M ﹤0.01% 1661
2023
Q1
$2.02M Buy
29,862
+17,272
+137% +$1.18M 0.02% 591
2022
Q4
$826K Buy
+12,590
New +$761K 0.01% 1077
2021
Q4
Sell
-8,909
Closed -$637K 3414
2021
Q3
$637K Buy
8,909
+6,229
+232% +$459K ﹤0.01% 1772
2021
Q2
$234K Buy
+2,680
New +$199K ﹤0.01% 2301

Other funds holding ESTA

HRT Financial's ESTA Position: Q1 2026 in Review

HRT Financial increased its Establishment Labs (ESTA) stake by 3.6% in Q1 2026, buying an estimated $259K and bringing the position to 108,802 shares worth $6.18M. The position accounts for 0.02% of the portfolio, ranked #880.

HRT Financial first reported a position in ESTA in Q2 2021 and has held it in 8 quarters since. The position peaked at $7.65M in Q4 2025. 176 funds tracked by Wall St. Rank hold ESTA as of Q1 2026.

  • HRT Financial held 108,802 shares of Establishment Labs worth $6.18M as of Q1 2026.
  • HRT Financial bought 3,790 Establishment Labs shares in Q1 2026, an estimated $259K.
  • Establishment Labs made up 0.02% of HRT Financial's portfolio in Q1 2026, its #880 holding.
  • HRT Financial first reported a position in Establishment Labs in Q2 2021 and has held it in 8 quarters since.
  • HRT Financial's Establishment Labs position peaked at $7.65M in Q4 2025.
  • 176 funds tracked by Wall St. Rank held Establishment Labs as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.